New hope for kids: malaria relapse drug tested in PNG
NCT ID NCT07052162
First seen Mar 23, 2026 · Last updated May 22, 2026 · Updated 11 times
Summary
This study tests a drug called tafenoquine in 30 children in Papua New Guinea who have vivax malaria. Vivax malaria can come back because it hides in the liver. The goal is to see if tafenoquine is safe and works well to completely clear the infection and prevent relapses. Researchers will measure how the drug moves through the body and check for side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PHARMACOKINETICS OF TAFENOQUINE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Alexishafen Health Centre
RECRUITINGMadang, Madang Province, MP511, Papua New Guinea
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.